| 1 |
Zhao X, Lu J, Zhang C, Chen C, Zhang M, Zhang J, Du Q, Wang H. Methamphetamine induces cardiomyopathy through GATA4/NF-κB/SASP axis-mediated cellular senescence. Toxicol Appl Pharmacol 2023;:116457. [PMID: 36914120 DOI: 10.1016/j.taap.2023.116457] [Reference Citation Analysis]
|
| 2 |
Opitz A, Petasch MS, Klappauf R, Kirschgens J, Hinz J, Dittmann L, Dathe AS, Quednow BB, Beste C, Stock AK. Does chronic use of amphetamine-type stimulants impair interference control? - A meta-analysis. Neurosci Biobehav Rev 2023;146:105020. [PMID: 36581170 DOI: 10.1016/j.neubiorev.2022.105020] [Reference Citation Analysis]
|
| 3 |
Zhu Z, Liu H, Ding P, Fu Y, Cao H, Xu W, He Q, Cheng J. Direct Active Site at the Van der Waals Heterostructure Interface with Synthetic Drug Analogue N-Methylphenethylimine Ultrasensitivity. ACS Sens 2023. [PMID: 36795762 DOI: 10.1021/acssensors.2c02829] [Reference Citation Analysis]
|
| 4 |
Young JW, Kenton JA, Milienne-Petiot M, Deben D, Achim C, Geyer MA, Perry W, Grant IE, Minassian A; TMARC. Chronic methamphetamine exposure exerts few effects on the iTat mouse model of HIV, but blocks Tat expression-induced slowed reward retrieval. Behav Brain Res 2023;437:114109. [PMID: 36108778 DOI: 10.1016/j.bbr.2022.114109] [Reference Citation Analysis]
|
| 5 |
Munoz C, Jayanthi S, Ladenheim B, Cadet JL. Compulsive methamphetamine self-administration in the presence of adverse consequences is associated with increased hippocampal mRNA expression of cellular adhesion molecules. Front Mol Neurosci 2022;15:1104657. [PMID: 36710935 DOI: 10.3389/fnmol.2022.1104657] [Reference Citation Analysis]
|
| 6 |
Morinaka H, Kaizaki-Mitsumoto A, Morohoshi H, Uchida N, Numazawa S. Urinary profiles of methoxyphenamine and its metabolite after inhalation of methoxyphenamine smoke in humans: aiming to distinguish between active and passive exposure. Forensic Toxicol 2023. [PMID: 36607477 DOI: 10.1007/s11419-022-00658-2] [Reference Citation Analysis]
|
| 7 |
Hámor PU, Knackstedt LA, Schwendt M. The role of metabotropic glutamate receptors in neurobehavioral effects associated with methamphetamine use. Int Rev Neurobiol 2023;168:177-219. [PMID: 36868629 DOI: 10.1016/bs.irn.2022.10.005] [Reference Citation Analysis]
|
| 8 |
Liang M, Chen G, Xi Z, Qian H, Shang Q, Gao B, An R, Shao G, Wang Z, Wang J, Xiao J, Li T, Liu X. The roles of K(+)-dependent Na(+)/Ca(2+) exchanger 2 (NCKX2) in methamphetamine-induced behavioral sensitization and conditioned place preference in mice. Neurosci Lett 2023;792:136952. [PMID: 36336087 DOI: 10.1016/j.neulet.2022.136952] [Reference Citation Analysis]
|
| 9 |
Luo H, Li X, Fan R, Ruan Y, Qian L, Shen Y, Si Z, Li L, Liu Y. Neuroprotective effect of histamine H3 receptor blockade on methamphetamine-induced cognitive impairment in mice. Pharmacol Biochem Behav 2023;222:173512. [PMID: 36572112 DOI: 10.1016/j.pbb.2022.173512] [Reference Citation Analysis]
|
| 10 |
Oflu S, Erarpat S, Zaman BT, Günkara ÖT, Bakırdere S, Turak F. Combination of quadrupole isotope dilution mass spectrometry with simultaneous derivatization and spray assisted droplet formation-liquid phase microextraction for the determination of methamphetamine in human urine and serum samples by gas chromatography mass spectrometry. J Pharmacol Toxicol Methods 2023;119:107207. [PMID: 35933004 DOI: 10.1016/j.vascn.2022.107207] [Reference Citation Analysis]
|
| 11 |
Yan P, Liu J, Ma H, Feng Y, Cui J, Bai Y, Huang X, Zhu Y, Wei S, Lai J. Effects of glycogen synthase kinase-3β activity inhibition on cognitive, behavioral, and hippocampal ultrastructural deficits in adulthood associated with adolescent methamphetamine exposure. Front Mol Neurosci 2023;16:1129553. [PMID: 36949769 DOI: 10.3389/fnmol.2023.1129553] [Reference Citation Analysis]
|
| 12 |
Salas-gonzález C, Gudayol-ferre E, Villuendas-gonzález ER, Padros-blázquez F, González-ramírez V, Murillo-servín AK. Memory and Executive Function Deficits in Abstinent Patients with Methamphetamine Use Disorder. Int J Ment Health Addiction 2022. [DOI: 10.1007/s11469-022-00939-2] [Reference Citation Analysis]
|
| 13 |
Highgate Q, Abadey AA, Schenk S. Repeated eticlopride administration increases dopamine D2 receptor expression and restores behavioral flexibility disrupted by methamphetamine exposure to male rats. Behav Brain Res 2022;435:114064. [PMID: 35987306 DOI: 10.1016/j.bbr.2022.114064] [Reference Citation Analysis]
|
| 14 |
Zhang C, Chen C, Zhao X, Lu J, Zhang M, Qiu H, Yue X, Wang H. New insight into methamphetamine-associated heart failure revealed by transcriptomic analyses: Circadian rhythm disorder. Toxicol Appl Pharmacol 2022;451:116172. [PMID: 35863504 DOI: 10.1016/j.taap.2022.116172] [Reference Citation Analysis]
|
| 15 |
Zhou Y, Hu Y, Wang Q, Yang Z, Li J, Ma Y, Wu Q, Chen S, Yang D, Hao Y, Wang Y, Li M, Peng P, Liu T, Yang WFZ. Association between white matter microstructure and cognitive function in patients with methamphetamine use disorder. Hum Brain Mapp 2023;44:304-14. [PMID: 35838008 DOI: 10.1002/hbm.26020] [Reference Citation Analysis]
|
| 16 |
Song F, Cao S, Liu Z, Su H, Chen Z. Different decorated ZIF-67 adsorption performance towards methamphetamine revealed by theoretical and experimental investigations. Journal of Molecular Liquids 2022;364:119950. [DOI: 10.1016/j.molliq.2022.119950] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 17 |
Shen B, Zhang D, Zeng X, Guan L, Yang G, Liu L, Huang J, Li Y, Hong S, Li L. Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway. Psychopharmacology (Berl) 2022;239:1521-37. [PMID: 34997862 DOI: 10.1007/s00213-021-06051-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Daiwile AP, Sullivan P, Jayanthi S, Goldstein DS, Cadet JL. Sex-Specific Alterations in Dopamine Metabolism in the Brain after Methamphetamine Self-Administration. IJMS 2022;23:4353. [DOI: 10.3390/ijms23084353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
